CJC NO DAC
Testing pending — unavailable for purchase until documentation is received, reviewed, and matched
Choose labeled amount
Current list price
$38.00
5 mg · single vial
Use restrictions
Poise materials are supplied solely for nonclinical laboratory work. Do not administer them to people or animals or use them for self-experimentation, clinical investigation or diagnosis. Food, cosmetic, household and treatment applications are excluded.
Testing Report (COA)
No reports are currently published on this website for this item.
Compound Information
- Reference identity
- Modified GRF(1–29) / CJC-1295 without DAC
- Residue count
- 29 residues
- Reference formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol (reference representation)
- Reference CAS
- No form-specific CAS identifier is asserted for this reference representation.
- Reference sequence
- H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2Sequence source
- Reference notes
- D-Ala at residue 2 and a C-terminal amide; no drug-affinity complex (DAC).
- Chemical source
- PubChem CID 91976842
- Physical form
- Supplied as a solid in a vial. Consult the applicable lot record for appearance details.
- Selected composition
- Single-component labeled material: 5 mg.
- Lot boundary
- Reference chemistry and sequences do not prove a supplied lot’s identity or composition. The label and lot record define the supported composition details. Excipients, counter-ions and hydration are unspecified unless those records identify them.
- Storage boundary
- Use the conditions specified for the exact lot, including any temperature limits. Protect the closed container from moisture and light, document excursions, and do not assume a shelf life that the supporting record does not establish.
- Handling boundary
- Handling is restricted to personnel trained for laboratory work. Choose protective equipment and containment under your institution's procedures, prevent material from contacting skin or eyes, and avoid creating airborne particles.
Reference depiction
Molecular structure

RDKit sequence-derived 2D depiction · Reference CID 91976842 · 2026-10-13Drawn from Table 1 including D-Ala at residue 2 and C-terminal amidation; CID 91976842 leaves peptide stereocenters unspecified.
Research literature
Published research is separate from the evidence for a supplied vial. These links identify literature about the material, not findings for your selected amount or instructions for use.
- Detection of GHRH synthetic analogs
Memdouh S et al. · Drug Testing and Analysis · 2021
Analytical method study · In vitro metabolism systems and fortified urine samples
Findings: Researchers characterized metabolites of GHRH analogs, including CJC-1295 without DAC, and developed a sensitive LC-MS/MS detection method.
Limitations: This study concerns chemical identification and metabolism, not clinical efficacy; findings about CJC-1295 with DAC cannot be transferred to the no-DAC form.
DOI: 10.1002/dta.3183

